Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Zoetis Inc Class A (ZTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,216,784
  • Shares Outstanding, K 483,860
  • Annual Sales, $ 5,307 M
  • Annual Income, $ 864,000 K
  • 36-Month Beta 0.98
  • Price/Sales 8.11
  • Price/Cash Flow 30.46
  • Price/Book 21.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.40 +5.89%
on 05/29/18
89.25 -2.24%
on 06/15/18
+2.85 (+3.38%)
since 05/18/18
3-Month
77.00 +13.31%
on 05/02/18
89.25 -2.24%
on 06/15/18
+4.10 (+4.93%)
since 03/19/18
52-Week
59.50 +46.64%
on 08/08/17
89.25 -2.24%
on 06/15/18
+24.22 (+38.43%)
since 06/19/17

Most Recent Stories

More News
SmarTrend Watching for Potential Rebound in Shares of Zoetis Inc After 1.99% Loss

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $86.63 to a high of $88.43. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $87.26 on...

ZTS : 87.25 (-1.89%)
Blog Exposure - Regeneron Inks Five-Year Collaboration Deal with Zoetis to Discover Antibody Therapies in Animal Health

LONDON, UK / ACCESSWIRE / June 08, 2018 / If you want access to our free research report on Regeneron Pharma, Inc. (NASDAQ: ) ("Regeneron"), all you need to do is sign up now by clicking the following...

ZTS : 87.25 (-1.89%)
REGN : 327.07 (+3.63%)
Zoetis Inc Set to Possibly Pullback After Yesterday's Rally of 1.24%

Zoetis Inc (NYSE:ZTS) traded in a range yesterday that spanned from a low of $85.45 to a high of $87.39. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $85.98...

ZTS : 87.25 (-1.89%)
Zoetis to Participate in the William Blair 2018 Growth Stock Conference

Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 2018 Growth Stock Conference on Tuesday, June 12, 2018, in Chicago, Ill. Juan Ramon Alaix, Chief Executive Officer, will...

ZTS : 87.25 (-1.89%)
Regeneron and Zoetis Announce Collaboration to Research Antibody Therapies for Use in Animal Health

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Zoetis Inc. (NYSE:ZTS) today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover...

ZTS : 87.25 (-1.89%)
REGN : 327.07 (+3.63%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Abaxis, Inc. - ABAX

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Abaxis Inc. ("Abaxis"...

ABAX : 83.05 (+0.02%)
ZTS : 87.25 (-1.89%)
Lifshitz & Miller LLP Announces Investigation of Abaxis, Inc., AeroVironment, Inc., Gramercy Property Trust, Mitel Networks Corporation, Molina Healthcare, Inc., Rockwell Medical, Inc., and Symantec Corporation

Abaxis, Inc. (ABAX)

MITL : 10.95 (unch)
AVAV : 57.78 (-4.12%)
ABAX : 83.05 (+0.02%)
RMTI : 5.46 (+0.92%)
MOH : 96.86 (+0.33%)
ZTS : 87.25 (-1.89%)
GPT : 27.59 (-0.33%)
SYMC : 20.99 (-0.80%)
Why Is Zoetis (ZTS) Up 5.7% Since Its Last Earnings Report?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZTS : 87.25 (-1.89%)
Zoetis to Participate in the Stifel 2018 Dental & Veterinary Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2018 Dental & Veterinary Conference on Wednesday, May 30, 2018, in New York, N.Y. Kristin Peck, Executive Vice President and Group...

ZTS : 87.25 (-1.89%)
Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug

Novartis' (NVS) CGRP antibody, Aimovig gains FDA approval for prevention of migraine. Zoetis (ZTS) and Lilly (LLY) announce deals to buy smaller companies.

AZN : 35.94 (-0.44%)
JNJ : 122.57 (+1.03%)
LLY : 86.82 (+0.82%)
ZTS : 87.25 (-1.89%)
NVS : 73.57 (-0.70%)
TEVA : 24.05 (-0.70%)
AMGN : 186.19 (+1.22%)
PFE : 36.22 (+0.17%)
GSK : 41.04 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ZTS with:

Business Summary

Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.

See More

Key Turning Points

2nd Resistance Point 89.23
1st Resistance Point 88.24
Last Price 87.25
1st Support Level 86.44
2nd Support Level 85.64

See More

52-Week High 89.25
Last Price 87.25
Fibonacci 61.8% 77.89
Fibonacci 50% 74.38
Fibonacci 38.2% 70.86
52-Week Low 59.50

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar